A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease

被引：0
|
作者：
Relja, M.
Klepac, N.
机构：
来源：
MOVEMENT DISORDERS | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P516
引用
收藏
页码：S468 / S468
页数：1
相关论文
共 50 条
  • [31] Dopamine agonist withdrawal syndrome in Parkinson's disease
    Solla, Paolo
    Cannas, Antonino
    Marrosu, Francesco
    Fasano, Alfonso
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 382 : 47 - 48
  • [32] Pramipexole in Parkinson's disease. A short-term study using the combined levodopa-dopamine agonist test
    Fabbrini, G
    Barbanti, P
    Aurilia, C
    Pauletti, C
    Meco, G
    FUNCTIONAL NEUROLOGY, 2002, 17 (04) : 199 - 201
  • [33] Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease (vol 49, pg 724, 1997)
    Shannon
    NEUROLOGY, 1998, 50 (03) : 838 - 838
  • [34] The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease
    Ahlskog, JE
    Uitti, RJ
    O'Connor, MK
    Maraganore, DM
    Matsumoto, JY
    Stark, KF
    Turk, MF
    Burnett, OL
    MOVEMENT DISORDERS, 1999, 14 (06) : 940 - 946
  • [35] Pramipexole and ropinirole for Parkinson's disease
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1997, 39 (1014): : 109 - 110
  • [36] Dopamine Agonist Withdrawal Syndrome and Suicidality in Parkinson's Disease
    Kwan, Cynthia
    Kolivakis, Theodore
    Huot, Philippe
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2023, 50 (05) : 779 - 780
  • [37] Fatigue in Parkinson's disease, effectiveness of dopamine agonist therapy
    Nodel, M.
    Yackno, N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 543 - 543
  • [38] Treatment of Parkinson's disease should begin with a dopamine agonist
    Montastruc, JL
    MOVEMENT DISORDERS, 2000, 15 (02) : 361 - 362
  • [39] Dopaminergic agonist and cognitive function in Parkinson's disease
    Relja, M
    Klepac, N
    Subotic, Z
    PERIODICUM BIOLOGORUM, 2002, 104 (01) : 43 - 45
  • [40] Rationale for dopamine agonist use as monotherapy in Parkinson's disease
    Schwarz, J
    CURRENT OPINION IN NEUROLOGY, 2003, 16 : S27 - S33
12345